129 related articles for article (PubMed ID: 12699763)
1. The selective inhibition of phosphatases by natural toxins: the anhydride domain of tautomycin is not a primary factor in controlling PP1/PP2A selectivity.
Liu W; Sheppeck JE; Colby DA; Huang HB; Nairn AC; Chamberlin AR
Bioorg Med Chem Lett; 2003 May; 13(9):1597-600. PubMed ID: 12699763
[TBL] [Abstract][Full Text] [Related]
2. Different moieties of tautomycin involved in protein phosphatase inhibition and induction of apoptosis.
Kawamura T; Matsuzawa S; Mizuno Y; Kikuchi K; Oikawa H; Oikawa M; Ubukata M; Ichihara A
Biochem Pharmacol; 1998 Apr; 55(7):995-1003. PubMed ID: 9605423
[TBL] [Abstract][Full Text] [Related]
3. A new model of the tautomycin-PP1 complex that is not analogous to the corresponding okadaic acid structure.
Colby DA; Liu W; Sheppeck JE; Huang HB; Nairn AC; Chamberlin AR
Bioorg Med Chem Lett; 2003 May; 13(9):1601-5. PubMed ID: 12699764
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of [18,19,21,22-(13)C4]-labeled tautomycin as an NMR probe of protein phosphatase inhibitor.
Isobe M; Kurono M; Tsuboi K; Takai A
Chem Asian J; 2007 Mar; 2(3):377-85. PubMed ID: 17441173
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of ttmM unveils new tautomycin analogs and insight into tautomycin biosynthesis and activity.
Ju J; Li W; Yuan Q; Peters NR; Hoffmann FM; Rajski SR; Osada H; Shen B
Org Lett; 2009 Apr; 11(7):1639-42. PubMed ID: 19281218
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of specific protein phosphatase inhibitors, tautomycin and tautomycetin toward structure-activity relationship study.
Oikawa H
Curr Med Chem; 2002 Nov; 9(22):2033-53. PubMed ID: 12369869
[TBL] [Abstract][Full Text] [Related]
7. The apoptosis-inducing activity of the two protein phosphatase inhibitors, tautomycin and thyrsiferyl 23-acetate, is not due to the inhibition of protein phosphatases PP1 and PP2A (review).
Kikuchi K; Shima H; Mitsuhashi S; Suzuki M; Oikawa H
Int J Mol Med; 1999 Oct; 4(4):395-401. PubMed ID: 10493981
[TBL] [Abstract][Full Text] [Related]
8. A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.
Gupta V; Ogawa AK; Du X; Houk KN; Armstrong RW
J Med Chem; 1997 Sep; 40(20):3199-206. PubMed ID: 9379439
[TBL] [Abstract][Full Text] [Related]
9. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors.
Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S
J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807
[TBL] [Abstract][Full Text] [Related]
10. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.
McCluskey A; Bowyer MC; Collins E; Sim ATR ; Sakoff JA; Baldwin ML
Bioorg Med Chem Lett; 2000 Aug; 10(15):1687-90. PubMed ID: 10937725
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.
Kelker MS; Page R; Peti W
J Mol Biol; 2009 Jan; 385(1):11-21. PubMed ID: 18992256
[TBL] [Abstract][Full Text] [Related]
12. A pharmacophore model of tautomycin, an inhibitor of protein phosphatases 1 and 2A.
Ubukata M; Koshino H; Yamasaki C; Fujita K; Isono K
J Antibiot (Tokyo); 1997 Oct; 50(10):801-7. PubMed ID: 9402983
[No Abstract] [Full Text] [Related]
13. Total synthesis of dinophysistoxin-2 and 2-epi-dinophysistoxin-2 and their PPase inhibition.
Pang Y; Fang C; Twiner MJ; Miles CO; Forsyth CJ
Angew Chem Int Ed Engl; 2011 Aug; 50(33):7631-5. PubMed ID: 21726026
[No Abstract] [Full Text] [Related]
14. Effects of modification of the hydrophobic C-1-C-16 segment of tautomycin on its affinity to type-1 and type-2A protein phosphatases.
Takai A; Tsuboi K; Koyasu M; Isobe M
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):81-8. PubMed ID: 10926829
[TBL] [Abstract][Full Text] [Related]
15. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
[TBL] [Abstract][Full Text] [Related]
16. Natural products with maleic anhydride structure: nonadrides, tautomycin, chaetomellic anhydride, and other compounds.
Chen X; Zheng Y; Shen Y
Chem Rev; 2007 May; 107(5):1777-830. PubMed ID: 17439289
[No Abstract] [Full Text] [Related]
17. Synthesis of a C1-C21 subunit of the protein phosphatase inhibitor tautomycin: a formal total synthesis.
Marshall JA; Yanik MM
J Org Chem; 2001 Feb; 66(4):1373-9. PubMed ID: 11312969
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways.
Chatfield K; Eastman A
Biochem Biophys Res Commun; 2004 Oct; 323(4):1313-20. PubMed ID: 15451440
[TBL] [Abstract][Full Text] [Related]
19. Effect of inhibitors of protein phosphatase 1 and 2A on erythroid colony formation: an investigation of the specificities of inhibitors.
Zhang W; Tamura J; Sakuraya M; Naruse T; Kubota K
J Int Med Res; 2001; 29(2):114-8. PubMed ID: 11393344
[TBL] [Abstract][Full Text] [Related]
20. Tautomycin's interactions with protein phosphatase 1.
Sydnes MO; Isobe M
Chem Asian J; 2010 Mar; 5(3):410-20. PubMed ID: 20013999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
